Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 2911 AL 2925

The Body, the Brain, the Environment, and Parkinson's Disease

Dorsey ER, De Miranda BR, Horsager J, Borghammer P.

J Parkinsons Dis. 2024;14(3):363-381. doi: 10.3233/JPD-240019.

Effectiveness and Feasibility of Nonpharmacological Interventions for People With Parkinson's Disease and Cognitive Impairment on Patient-Centred Outcomes: Systematic Review and Meta-Analysis

Pigott JS, Armstrong M, Tabassum N, Davies N, Schrag A.

Parkinsons Dis. 2024 Nov 18;2024:3654652. doi: 10.1155/2024/3654652. eCollection 2024.

Communal interaction of glycation and gut microbes in diabetes mellitus, Alzheimer's disease, and Parkinson's disease pathogenesis

Patil RS, Tupe RS.

Med Res Rev. 2024 Jan;44(1):365-405. doi: 10.1002/med.21987. Epub 2023 Aug 17.

Astrocytic transcription factors REST, YY1, and putative microRNAs in Parkinson's disease and advanced therapeutic strategies

Nassar A, Kodi T, Satarker S, Gurram PC, Fayaz SM, Nampoothiri M.

Gene. 2024 Jan 20;892:147898. doi: 10.1016/j.gene.2023.147898. Epub 2023 Oct 11.

Underserved groups in dysphagia intervention trials in Parkinson's disease: A scoping review

Hirschwald J, Finnegan L, Hofacker J, Walshe M.

Ageing Res Rev. 2024 Jan;93:102150. doi: 10.1016/j.arr.2023.102150. Epub 2023 Dec 2.

Mitochondrial homeostasis regulation: A promising therapeutic target for Parkinson's disease

Yao MF, Dang T, Wang HJ, Zhu XZ, Qiao C.

Behav Brain Res. 2024 Feb 29;459:114811. doi: 10.1016/j.bbr.2023.114811. Epub 2023 Dec 14.

How to Use the New European Academy of Neurology/Movement Disorder Society European Section Guideline for Invasive Therapies in Parkinson's Disease

Brinker D, Smilowska K, Paschen S, Antonini A, Moro E, Deuschl G.

Mov Disord Clin Pract. 2024 Mar;11(3):209-219. doi: 10.1002/mdc3.13962. Epub 2024 Jan 12.

Action Observation and Motor Imagery as a Treatment in Patients with Parkinson's Disease

Mezzarobba S, Bonassi G, Avanzino L, Pelosin E.

J Parkinsons Dis. 2024;14(s1):S53-S64. doi: 10.3233/JPD-230219.

What Can Inflammation Tell Us about Therapeutic Strategies for Parkinson's Disease?

Xue J, Tao K, Wang W, Wang X.

Int J Mol Sci. 2024 Jan 29;25(3):1641. doi: 10.3390/ijms25031641.

Pharmacotherapy for Disease Modification in Early Parkinson's Disease: How Early Should We Be?

Mahlknecht P, Poewe W.

J Parkinsons Dis. 2024;14(s2):S407-S421. doi: 10.3233/JPD-230354.

Parkinson's Disease and MicroRNAs: A Duel Between Inhibition and Stimulation of Apoptosis in Neuronal Cells

Saadh MJ, Faisal A, Adil M, Zabibah RS, Mamadaliev AM, Jawad MJ, Alsaikhan F, Farhood B.

Mol Neurobiol. 2024 Nov;61(11):8552-8574. doi: 10.1007/s12035-024-04111-w. Epub 2024 Mar 23.

GLP-1 Receptor Agonists: A New Treatment in Parkinson's Disease

Kalinderi K, Papaliagkas V, Fidani L.

Int J Mol Sci. 2024 Mar 29;25(7):3812. doi: 10.3390/ijms25073812.

The palliative care needs and experiences of patients with advanced Parkinson's disease: a qualitative scoping review

Lou Y, Li Y, Chen Y.

Front Med (Lausanne). 2024 Apr 10;11:1362828. doi: 10.3389/fmed.2024.1362828. eCollection 2024.

Gut-directed therapy in Parkinson's disease

Benvenuti L, Di Salvo C, Bellini G, Seguella L, Rettura F, Esposito G, Antonioli L, Ceravolo R, Bernardini N, Pellegrini C, Fornai M.

Front Pharmacol. 2024 Jun 21;15:1407925. doi: 10.3389/fphar.2024.1407925. eCollection 2024.

Crosstalk between gut-brain axis: unveiling the mysteries of gut ROS in progression of Parkinson's disease

Soni D, Upadhayay S, Dhureja M, Arthur R, Kumar P.

Inflammopharmacology. 2024 Oct;32(5):2921-2941. doi: 10.1007/s10787-024-01510-2. Epub 2024 Jul 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias